“Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer” (2026) Journal of Cancer Research Updates, 15(3), pp. 186–196. doi:10.30683/1929-2279.2026.15.17.